Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Blood Advances|October 25, 2019
Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapyMazyar Shadman, Jordan Gauthier, Kevin A Hay, et al.
Leukemia & Lymphoma|April 9, 2014
Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivityColin Phipps, Ajay K Gopal, Barry E Storer, et al.
Blood|August 10, 2019
The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease modelShyril O'Steen, Melissa L Comstock, Johnnie J Orozco, et al.
Blood|November 22, 2017
CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignanciesDamian J Green, Shyril O'Steen, Yukang Lin, et al.
British Journal of Haematology|February 12, 2022
The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic lymphocytic leukaemiaChaitra Ujjani, Mazyar Shadman, Ryan C Lynch, et al.
Cancer Research|September 4, 2016
Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell CancersDamian J Green, Shani L Frayo, Yukang Lin, et al.
British Journal of Haematology|May 3, 2019
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United StatesMarcus Geer, Emily Roberts, Maryann Shango, et al.
Nature Communications|April 6, 2026
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody responseStosh Ozog, Elizabeth M Krantz, Karyn Tindbaek, et al.
Pageof 8